Cannabis Does Not Impact Nonmedical Opioid Use in Opioid Use Disorder
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 16, 2024 -- For patients receiving pharmacotherapies for opioid use disorder (OUD), cannabis use is not associated with nonmedical opioid use, according to a systematic review and meta-analysis published online Jan. 16 in the American Journal of Drug and Alcohol Abuse.
Gabriel P.A. Costa, from the University of Ribeirão Preto in Brazil, and colleagues examined the impact of cannabis use on the risk for nonmedical opioid use among individuals receiving pharmacotherapies for OUD. Ten studies, with 8,367 participants and an average follow-up time of 9.7 months, were included in the final meta-analysis.
The pharmacotherapies involved were methadone, buprenorphine, and naltrexone (76.3, 21.3, and 2.4 percent, respectively). The researchers found that based on pooled odds ratios, cannabis use did not significantly influence nonmedical opioid use (odds ratio, 1.00; 95 percent confidence interval, 0.97 to 1.04; P = 0.98). Evidence of moderate heterogeneity and publication bias was observed.
"These findings neither confirm concerns about cannabis increasing nonmedical opioid use in individuals being treated for opioid use disorder, nor do they endorse its efficacy in reducing nonmedical opioid use," Costa said in a statement.
One author disclosed ties to Jazz Pharmaceuticals and Boehringer Ingelheim.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Slight Decline Seen in U.S. Drug Overdose Deaths
THURSDAY, May 16, 2024 -- New 2023 provisional data from the National Center for Health Statistics show the first decline in deaths from drug overdose in the United States since...
American Psychiatric Association, May 4-8
The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...
Number, Size of Seizures of Fentanyl Increasing in the United States
MONDAY, May 13, 2024 -- The number and size of seizures of fentanyl are increasing in the United States, with most seizures occurring in the West, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.